tiprankstipranks
Xilio Therapeutics Inc (XLO)
NASDAQ:XLO
US Market
XLO
Xilio Therapeutics
RESEARCH TOOLSreports

Xilio Therapeutics (XLO) Income Statement

219 Followers

Xilio Therapeutics Income Statement

Last quarter (Q4 2025), Xilio Therapeutics's total revenue was $13.69M, an increase of 693.85% from the same quarter last year. In Q4, Xilio Therapeutics's net income was $10.36M. See Xilio Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 43.77M$ 6.34M$ 0.00$ 0.00$ 0.00
Gross Profit
$ 42.23M$ 6.34M$ 0.00$ 0.00$ -1.50M
Operating Expenses
$ 84.21M$ 66.93M$ 79.13M$ 89.15M$ 73.55M
Depreciation and Amortization
$ 1.54M$ 1.64M$ 1.90M$ 1.85M$ 1.50M
EBITDA
$ -40.44M$ -58.00M$ -77.23M$ -87.30M$ -73.70M
Operating Income
$ -41.98M$ -60.58M$ -79.13M$ -89.15M$ -75.04M
Other Income/Expenses
$ 6.95M$ 2.34M$ 2.73M$ 927.00K$ -756.00K
Pretax Income
$ -35.04M$ -58.24M$ -76.40M$ -88.22M$ -75.80M
Net Income
$ -35.04M$ -58.24M$ -76.40M$ -88.22M$ -75.80M
Per Share Metrics
Basic EPS
$ -4.19$ -15.26$ -38.92$ -45.08$ -189.28
Diluted EPS
$ -4.19$ -15.26$ -38.92$ -45.08$ -189.28
Weighted Average Shares Outstanding
 83.59M----
Weighted Average Shares Outstanding (Diluted)
 83.59M----
Currency in USD

Xilio Therapeutics Earnings and Revenue History